NASDAQ:BRKR Bruker (BRKR) Stock Price, News & Analysis $56.46 -5.64 (-9.08%) Closing price 11/20/2026 04:00 PM EasternExtended Trading$57.73 +1.27 (+2.25%) As of 11/20/2026 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Bruker Stock (NASDAQ:BRKR) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Bruker alerts:Sign Up Key Stats Today's Range$56.13▼$61.1050-Day Range$52.66▼$66.5452-Week Range$32.37▼$68.98Volume2.25 million shsAverage Volume2.56 million shsMarket Capitalization$8.62 billionP/E RatioN/ADividend Yield0.35%Price Target$61.00Consensus RatingHold Company Overview Bruker develops and manufactures scientific instruments and analytical technologies used to study biological, chemical and physical materials. Its products support research and testing in areas including life sciences, pharmaceuticals, biotechnology, materials science, chemicals and clinical diagnostics. The company’s offerings include nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray and microscopy instruments, and infrared and Raman spectroscopy solutions. Bruker also provides software, consumables and services related to its instruments. Founded in 1960 by physicist Günther Laukien, Bruker serves customers around the world, including universities, government research institutions and companies in scientific and industrial fields. The company is headquartered in Billerica, Massachusetts, and is led by President and Chief Executive Officer Frank H. Laukien.AI Generated. May Contain Errors. Read More Bruker Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks61st Percentile Overall ScoreBRKR MarketRank™: 3.03319849351 of 5 starsBruker scored higher than 61% of companies evaluated by MarketBeat, and ranked 473rd out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.9 / 5Analyst RatingHold Consensus RatingBruker has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 1 strong buy rating, 5 buy ratings, 7 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Bruker is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageBruker has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Bruker's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth13.15% Earnings GrowthEarnings for Bruker are expected to grow by 13.15% in the coming year, from $2.13 to $2.41 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Bruker is -51.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Bruker is -51.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioBruker has a PEG Ratio of 1.64. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioBruker has a P/B Ratio of 3.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted10.14% of the float of Bruker has been sold short.Short Interest Ratio / Days to CoverBruker has a short interest ratio ("days to cover") of 5.43.Change versus previous monthShort interest in Bruker has recently decreased by 11.22%, indicating that investor sentiment is improving significantly. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldBruker has a dividend yield of 0.35%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthBruker does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Bruker will have a dividend payout ratio of 8.30% next year. This indicates that Bruker will be able to sustain or increase its dividend.Read more about Bruker's dividend. News and Social Media3.0 / 5News Sentiment0.78 News SentimentBruker has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Bruker this week, compared to 5 articles on an average week.MarketBeat FollowsOnly 1 people have added Bruker to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Bruker insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $105,740.00 in company stock.Percentage Held by Insiders27.20% of the stock of Bruker is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions79.52% of the stock of Bruker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Bruker's insider trading history. Receive BRKR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bruker and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BRKR Stock News HeadlinesBruker (NASDAQ:BRKR) Stock Gets Downgrade from Wall Street ZenNovember 21 at 1:06 AM | americanbankingnews.comHas The Story Under Bruker Stock Run Out?November 17, 2026 | finance.yahoo.comPrediction: NVDA will “snap back” on this dateOthers paid $500 for the Snapback Indicator. For Black Friday, Base Camp Trading is offering lifetime access for just $7. The specialized indicator shows when a stock is likely to "snap back," helping traders avoid buying at the peak. It can also flag when a stock may bounce off the bottom so you can time your entry. Run NVDA or any other popular AI stock through it before you place a trade.November 21 at 1:00 AM | Base Camp Trading (Ad)Bruker Corporation Announces Appointment of Eicke Latz as Director, Effective January 1, 2027November 17, 2026 | marketscreener.comMBruker Expands Board, Appoints Immunology Leader Eicke LatzNovember 16, 2026 | tipranks.comBruker Earnings Call Signals Margin Gains Amid Uneven DemandNovember 16, 2026 | theglobeandmail.comBruker Announces that Institute Director, Biopharma Entrepreneur and Immunology Leader Dr. Eicke Latz will join its Board of DirectorsNovember 16, 2026 | marketscreener.comMBruker Corporation 2026 Q3 - Results - Earnings Call PresentationNovember 7, 2026 | seekingalpha.comSee More Headlines BRKR Stock Analysis - Frequently Asked Questions How have BRKR shares performed this year? Bruker's stock was trading at $47.11 at the start of the year. Since then, BRKR shares have increased by 19.8% and is now trading at $56.46. How were Bruker's earnings last quarter? Bruker Corporation (NASDAQ:BRKR) released its quarterly earnings results on Wednesday, November, 4th. The medical research company reported $0.56 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.42 by $0.14. The company's revenue for the quarter was up 1.6% on a year-over-year basis. Read the conference call transcript. Does Bruker have any subsidiaries? Bruker subsidiaries include these companies: PMOD Technologies, Arxspan, Alicona Imaging, JPK Instruments, Luxendo, Hysitron, InVivo Biotech Services GmbH, and others. Who are Bruker's major shareholders? Top institutional investors of Bruker include Edmond DE Rothschild Holding S.A. (1.73%), First Trust Advisors LP (1.00%), Barrow Hanley Mewhinney & Strauss LLC (0.66%) and Goldman Sachs Group Inc. (0.40%). Insiders that own company stock include Frank H Laukien, Mark Munch, John A Ornell, Hermann Fritz Requardt, Cynthia M Friend and Thomas Bures. View institutional ownership trends. How do I buy shares of Bruker? Shares of BRKR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Bruker own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bruker investors own include Advanced Micro Devices (AMD), Netflix (NFLX), NVIDIA (NVDA), Salesforce (CRM), Adobe (ADBE), Broadcom (AVGO) and Micron Technology (MU). Company Calendar Record date for 10/7 Dividend9/21/2026Ex-Dividend for 10/7 Dividend9/21/2026Dividend Payable10/07/2026Last Earnings11/04/2026Today11/21/2026Record date for 1/7 Dividend12/21/2026Ex-Dividend for 1/7 Dividend12/21/2026Fiscal Year End12/31/2026Dividend Payable1/07/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 BRKR's financial health is in the Green zone, according to TradeSmith. BRKR has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:BRKR CIK1109354 Webwww.bruker.com Phone(978) 663-3660Fax978-663-5585Employees11,085Year Founded1960Price Target and Rating Average Price Target for Bruker$61.00 High Price Target$85.00 Low Price Target$35.00 Potential Upside/Downside+8.0%Consensus RatingHold Rating Score (0-4)2.43 Research Coverage14 Analysts Profitability EPS (Trailing Twelve Months)($1.10) Trailing P/E Ratio28.95 Forward P/E Ratio23.43 P/E Growth1.64Net Income-$8.60 million Net Margins-3.82% Pretax Margin-2.02% Return on Equity13.76% Return on Assets5.47% Debt Debt-to-Equity Ratio0.74 Current Ratio1.84 Quick Ratio0.90 Sales & Book Value Annual Sales$3.44 billion Price / Sales2.51 Cash Flow$3.37 per share Price / Cash Flow16.73 Book Value$15.10 per share Price / Book3.74Miscellaneous Outstanding Shares152,720,000Free Float111,182,000Market Cap$8.62 billion OptionableOptionable Beta1.26 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:BRKR) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersPrediction: NVDA will “snap back” on this dateOthers paid $500 for the Snapback Indicator. For Black Friday, Base Camp Trading is offering lifetime access f...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bruker Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Bruker With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.